ØRSTAVIKØ,MANFRAO,ANDRESSEN KW,et al.The inotropic effect of the active metabolite of levosimendan,OR-1896,is mediated through inhibition of PDE3 in rat ventricular myocardium[J].,2015,10(3):e0115547.
[本文引用:1]
[5]
CAIMMI PP,MOLINARIC,UBERTIF,et al.Intracoronary levosimendan prevents myocardial ischemicdamages and activates survival signaling through ATP-sensitive potassiumchannel and nitric oxide[J].,2011,39(4):59-67.
RICCIZ,GARISTOC,FAVIAI,et al.Levosimendan infu-sion in newborns after corrective surgery for congenital heart disease:randomized controlled trial[J].,2012,38(7):1198-1204.
ANGADIU,WESTROPEC,CHOWDHRY MF.Is levosi-mendan effective in paediatric heart failure and post-cardiac surgeries?[J].,2013,17(4):710-714.
[本文引用:1]
[17]
VILABOA PEDROSAC,MARTINEZ ROCAC,YANEZ GOMEZP,et al.Experience with levosimendan in 32 paediatric patients[J].,2015,36(5):1038-1041.
[本文引用:2]
[18]
SUOMINEN PK.Single-center experience with levosime-ndan inchildren undergoing cardiacsurgery and in children with decompensated heart failure[J].,2011,11(1):18-23.
[本文引用:1]
[19]
PRIJICS,RAKICS,NIKOLICL,et al.Levosimendan treat-ment of severe acute congestive heart failure refractory to dobutamine/milrinone in children[J].,2011,68(11):979-984.
[本文引用:2]
[20]
PELLICERA,RIERAJ,LOPEZ-ORTEGOP,et al.Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery[J].,2013,73(1):95-103.
[本文引用:2]
[21]
LOBACHEVA GV,KHAR'KIN AV,MANEROVA AF,et al.Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions[J].Anesteziol Reanimatol,2010,9-10(5):23-27.
[本文引用:6]
[22]
EBADE AA,KHALIL MA,MOHAMED AK.Levosimen-dan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery[J].,2013,27(3):334-339.
[本文引用:1]
[23]
BRAVO MC,LOPEZP,CABANASF,et al.Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns:an observational study[J].,2011,99(3):217-223.
[本文引用:4]
[24]
LEONGM,FAIZAHK.Preliminary report of levosimendan use in infants with low cardiac output syndrome(LCOS) post cardiac surgery[J].,2011,12(3):A110.
[本文引用:1]
[25]
ALMASRIA,ALMEERIN,SHAWAFE,et al.Experience in the practical use of levosimendan in children in Kuwait[J].,2011,14(Suppl):19-22.
[本文引用:2]
[26]
BANILLEE,CACCIAMANOA,PEDERNERAE,et al.Levosimendan on severe low cardiac output in paediatric patients[J].,2011,21(Suppl):86-90.
[本文引用:1]
[27]
EBADE AA,KHALIL MA,MOHAMED AK.Levosi-mendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery[J].,2013,27(3):334-339.
[本文引用:1]
[28]
LECHNERE,HOFERA,LEITNER-PENEDERG,et al.Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery:a pilot study[J].,2012,13(5):542-548.
[本文引用:1]
[29]
LECHNERE,HOFERA,LEITNER-PENEDERG,et al.Levosimendan versus milrinone after corrective open-heart surgery in neonates and infants[J].,2011,21(Suppl):14-15.
[本文引用:1]
[30]
RYERSON LM,ALEXANDER PM,BUTT WW,et al.Rotating inotrope therapy in a pediatric population with decompensated heart failure[J].,2011,12(1):57-60.
[本文引用:1]
[31]
SCHWEIGMANNU,VELIK-SALCHNERC,KILOJ,et al.How mechanical circulatory support helps not to need it——new strategies in pediatric heart failure[J].,2011,35(11):1105-1109.
[本文引用:1]
[32]
FERNANDEZ DE PALENCIA-ESPINOSA M A,CARCE-LES-BARON MD,BLAZQUEZ-ALVAREZ MJ,et al.Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease[J].,2012,59(9):489-496.
Intracoronary levosimendan prevents myocardial ischemicdamages and activates survival signaling through ATP-sensitive potassiumchannel and nitric oxide